Global Vagus Nerve Stimulation Market 2017-2021

  • ID: 4115387
  • Report
  • Region: Global
  • 63 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Beijing Medical Equipment
  • BioControl Medica
  • ElectroCore
  • Enteromedics
  • LivaNova
  • MORE
About Vagus Nerve Stimulation

Neurostimulation devices help in the therapeutic activation of the nervous system. These implantable devices provide electrical stimulation to the brain, spinal cord, and nervous system. The neurostimulators transmit a target specific stimuli that inhibit the passage of pain signals to the brain. Healthcare professionals use these devices to treat various neurological disorders like pain, epilepsy, PD, depression, and obsessive-compulsive disorder.

The analysts forecast the global vagus nerve stimulation market to grow at a CAGR of 9.63% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global vagus nerve stimulation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of genomics biomarkers.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Vagus Nerve Stimulation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- LivaNova
- Enteromedics
- ElectroCore

Other prominent vendors
- Beijing Medical Equipment
- BioControl Medical

Market drivers
- Favorable reimbursement and insurance approval policies.
- For a full, detailed list, view the full report

Market challenges
- Stringent regulatory approvals and high cost of devices.
- For a full, detailed list, view the full report

Market trends
- Shift of surgeons focus toward minimally invasive VNS procedures.
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Beijing Medical Equipment
  • BioControl Medica
  • ElectroCore
  • Enteromedics
  • LivaNova
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by product

Implantable VNS devices

External VNS devices

PART 07: Market segmentation by end-user

PART 08: Geographical segmentation

VNS market in Americas

VNS market in EMEA

VNS market in APAC

PART 09: Market drivers

Increasing prevalence of neurological disorders

Favorable reimbursement and insurance approval policies

Rising demand for external VNS devices

PART 10: Impact of drivers

PART 11: Market challenges

Stringent regulatory approvals and high cost of devices

Complications related to VNS

High maintenance and low battery lifetime

PART 12: Impact of drivers and challenges

PART 13: Market trends

Shift of surgeons focus toward minimally invasive VNS procedures

Next-generation therapies for nervous system disorders

Application of VNS in other indications

PART 14: Vendor landscape

Competitive scenario

PART 15: Key vendor analysis

LivaNova

Enteromedics

ElectroCore

Key company to watch

Cerbomed

Other prominent vendors

PART 16: Appendix

List of abbreviations

PART 17: About the Author
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Beijing Medical Equipment
  • BioControl Medica
  • ElectroCore
  • Enteromedics
  • LivaNova
  • MORE
PR
New Report Released: – Global Vagus Nerve Stimulation Market 2017-2021

The author of the report recognizes the following companies as the key players in the global vagus nerve stimulation market: LivaNova, Enteromedics, and ElectroCore.

Other Prominent Vendors in the market are: Beijing Medical Equipment and BioControl Medica.

Commenting on the report, an analyst from the research team said: “One trend in market is shift of surgeons focus toward minimally invasive VNS procedures. Few years ago, VNS procedures were not popular or limited to few developed countries having high standards of healthcare infrastructure. But now, global exposure and availability of many innovative techniques for learning have increased the knowledge of surgeons about VNS devices. Increased communication among the medical fraternity across countries through various media like medical conferences and industrial exhibitions have made the surgeons receive updates about VNS devices. In the Americas, countries like the US and Canada have listed surgeries involving VNS devices in revenue generating category. The patients having resistance toward anti-epileptic drugs are being treated with VNS devices. Simultaneously, the focus of surgeons is increasing to minimize the side effects observed while using these devices.”

According to the report, one driver in market is favorable reimbursement and insurance approval policies. For any device to penetrate the market and later to sustain, depends on various factors, such as, positive results on using the device, user-friendliness, and cost of the device, low side effects, and favorable reimbursement policies. In case of VNS devices, most of the conditions are fulfilled, though some variations are observed based on the type of device. The market growth is expected to increase mainly due to the favorable reimbursement, leading to an increased application and significant investments in development of new technologies for the treatment of epilepsy, and other cardiac indications. As per the Centers for Medicare & Medicaid Services (CMS) coverage database, spinal cord stimulators are covered under reimbursement when criteria are met.

Further, the report states that one challenge in market is high maintenance and low battery lifetime. Battery enables the VNS system to operate for few years without any need of recharge or replacements. Though there are few factors that can drain the battery’s power. For instance, battery usage, battery chemistry, usage pattern, and self-discharge can drain the battery. VNS devices use battery power to control the motor neuron. To control dystonic symptom, involuntary muscle contraction that can cause slow and repetitive movement, consumes high battery power. These batteries can wear out in 7 to 10 years. Batteries are implanted in implantable VNS device that provides power to neural stimulation and to keep the device working. For VNS system, a neurostimulator is implanted in the chest.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • LivaNova
  • Enteromedics
  • ElectroCore
  • Beijing Medical Equipment
  • BioControl Medica
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll